Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist

Journal of Clinical and Aesthetic Dermatology

Volumn 5, Issue 4, 2012, Pages 36-39

  Wollina, Uwe ^a   Gemmeke, Astrid ^a   Koch, André ^a  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; IBUPROFEN; INFLIXIMAB; ISOTRETINOIN; PREDNICARBATE; PREDNISOLONE; RIFAMPICIN;

ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CELLULITIS; DISEASE SEVERITY; DISSECTING CELLULITIS; DRUG DOSE TITRATION; DRUG INFUSION; DRUG RESPONSE; HUMAN; INFLAMMATION; MALE; ODOR; PHYSICAL EXAMINATION; PSORIASIS; QUALITY OF LIFE; RASH; SCALP; SKIN BIOPSY; SKIN DISEASE; SKIN NODULE; SKIN PAIN; TREATMENT FAILURE;

EID: 84863680355     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hoffmann E. Perifolliculitis capitis abscedens et suffodiens: Ein Fallbericht. Dermatol Z. 1908;15:122-123.
2. Scheinfeld NS. A case of dissecting cellulitis and review of the literature. Dermatol Online J. 2003;9:8.
3. Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology. 2010;56:24-38.
4. Georgala S, Korfitis C, Ioannidu D, et al. Dissecting cellulitis of the scalp treated with rifampicin and isotretinoin: case reports. Cutis. 2008;82:195-198.
5. Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis abscedens et suffodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges. 2008;6:44-47.
6. Ljubojevic S, Pasic A, Lipozenzic J, Skerlev M. Perifolliculitis capitis abscendens et suffodiens. J Eur Acad Dermatol Venereol. 2005;19:719-721.
7. Karpouzis A, Giatromanolakia A, Sivridis E, Kouskoukis C. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin. J Eur Acad Dermatol Venereol. 2003;13:192-195. (Pubitemid 36428367)
8. Koca R, Altinyazar HC, Ozen OI, Tekin NS. Dissecting cellulitis in a white male: response to isotretinoin. Int J Dermatol. 2002;41:509-513. (Pubitemid 35023438)
9. Sivakumaran S, Meyer P, Burrows NP. Dissecting folliculitis of the scalp with marginal keratitis. Clin Exp Dermatol. 2001;26:490-492. (Pubitemid 32955456)
10. Bachynsky T, Antonyshyn ON, Ross JB. Dissecting folliculitis of the scalp. A case report of combined treatment using tissue expansion, radical excision, and isotretinoin. J Dermatol Surg Oncol. 1992;18:877-880.
11. Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol. 1981;4:673-678. (Pubitemid 11037997)
12. Silva LC, Ortigosa LC, Bernard G. Anti-TNF-á agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy. 2010;2:817-833.
13. Delage M, Samimi M, Atlan M, et al. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers. Acta Derm Venereol. 2011;91:169-171.
14. Sciaudone G, Di Stazio C, Limongelli P, et al. Treatment of complex perianal fistulas in Crohn's disease: infliximab, surgery or combined approach. Can J Surg. 2010;53:299-304.
15. Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-á inhibitor-induced psoriasis or psoriasiform exanthemata. First 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1-14.
16. Brandt HR, Malheiros AP, Teixeira MG, Machado MC. Perifolliculitis abscedens et suffodiens successfully controlled with infliximab. Br J Dermatol. 2008;159:506-507. (Pubitemid 352009862)